Answers are grounded in this paper and cite their sources.
Data could represent the baseline cost for COVID-19 hospital management, thus being useful for the further development of proper reimbursement tariffs devoted to hospitalized infected patients.
No takes yet. Share an insight, caveat, or question.
Foglia et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: